Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / January / Parkinson's Aggravated by Nanoplastics Exposure
Omics Clinical Omics Metabolomics & Lipidomics

Parkinson's Aggravated by Nanoplastics Exposure

Mouse study suggests environmental nanoplastics may exacerbate Parkinson's disease through metabolic dysregulation in the gut, brain, and liver

By Kathryn Wighton 01/27/2026 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Share

Top Institutions in Neurology and Neurodegenerative Disease Research

Leading institutions in neurology and neurodegenerative diseases employ advanced animal models, molecular biology techniques, metabolomics, microbiome analysis, and neuroinflammation assessments to elucidate environmental and molecular contributors to Parkinson's disease progression.

  • #1

    Johns Hopkins University

    Baltimore, MD

    Johns Hopkins is a global leader in Parkinson's disease research, with extensive expertise in α-synuclein pathology, neuroinflammation, and environmental factors influencing neurodegeneration. Their integration of advanced animal models and metabolomic profiling positions them at the forefront of studies linking environmental toxins to Parkinson's disease.

    Key Differentiators

    • Neurology
    • Neuroscience
    • Neurodegenerative Diseases
    • Environmental Health
  • #2

    University of California, San Francisco (UCSF)

    San Francisco, CA

    UCSF is renowned for its multidisciplinary approach to Parkinson's disease, including gut-brain axis research and microbiome studies, which are critical for understanding how environmental exposures like nanoplastics influence disease progression.

    Key Differentiators

    • Neurology
    • Neurodegenerative Disease
    • Microbiome Research
  • #3

    Massachusetts General Hospital (MGH) / Harvard Medical School

    Boston, MA

    MGH, affiliated with Harvard Medical School, has a robust Parkinson's disease research program emphasizing molecular mechanisms, environmental risk factors, and translational studies, including the use of advanced imaging and biomarker discovery.

    Key Differentiators

    • Neurology
    • Neurodegenerative Disorders
    • Environmental Neurology
  • #4

    National Institute of Environmental Health Sciences (NIEHS)

    Research Triangle Park, NC

    NIEHS leads in studying environmental exposures, including nanoplastics, and their effects on neurological health, integrating toxicology with neurodegenerative disease research to understand mechanisms of environmental contributions to Parkinson's disease.

    Key Differentiators

    • Environmental Health
    • Toxicology
    • Neurotoxicology
  • #5

    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Penn Medicine has significant expertise in Parkinson's disease mechanisms, including α-synuclein pathology and gut microbiome interactions, supported by advanced metabolomic and microbiological research platforms.

    Key Differentiators

    • Neurology
    • Neurodegenerative Disease
    • Microbiome and Metabolomics

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Kathryn Wighton

Editor, Conexiant

More Articles by Kathryn Wighton

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #7
Omics
The Analytical Scientist Innovation Awards 2024: #7

December 2, 2024

4 min read

Frank Steemers, co-founder and CSO of Scale Biosciences, tells us the story of ScalePlex – the 7th ranked innovation on this year’s Awards

The Analytical Scientist Innovation Awards 2024: #4
Omics
The Analytical Scientist Innovation Awards 2024: #4

December 5, 2024

6 min read

Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

Let Me See That Brain
Omics
Let Me See That Brain

December 9, 2024

1 min read

TRISCO sets a new standard for 3D RNA imaging, delivering high-resolution and uniform images to offer insights into brain function and anatomy

The Analytical Scientist Innovation Awards 2024
Omics
The Analytical Scientist Innovation Awards 2024

December 11, 2024

10 min read

Meet the products – and the experts – defining analytical innovation in 2024

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.